COMMON STOCKUnderwriting Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc • New York
COMMON STOCKUnderwriting Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
WITNESSETH:Investment Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.11 DEVELOPMENT AGREEMENTDevelopment Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
1 2 (a) "Development Agreement" shall mean the undated form of Development and Commercialization Agreement among Leiras, Berlex and Anthra identified as 4429/18/JKK, annexed hereto as Exhibit A and initialed by the parties for purposes of further...Option Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.9 EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
DATED DECEMBER, 1997 ---------------------------------- ALLEN-MARTIN CONSERVATION LIMITED to ANTHRA PHARMACEUTICALS LIMITEDAnthra Pharmaceuticals Inc • March 11th, 1998
AGREEMENTAgreement • March 11th, 1998 • Anthra Pharmaceuticals Inc • Massachusetts
1 Exhibit 4.3 FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT October , 1997 To each of the Several Purchasers (the "Purchasers") named in the signature pages of this Amended and Restated Registration Rights Agreement Ladies and Gentlemen:...Registration Rights Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc • New York
AGREEMENTAnthra Pharmaceuticals Inc • May 21st, 1998 • In vitro & in vivo diagnostic substances • Massachusetts
W I T N E S S E T H:Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc • New York
1 2 The Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc • New York
ADOPTION AGREEMENT FOR THE ABR BENEFITS SERVICES, INC. REGIONAL PROTOTYPE STANDARDIZED CASH OR DEFERRED PROFIT SHARING PLAN AND TRUST (WITH PAIRING PROVISIONS) ------------------------------------------------------------- 2 ADOPTION AGREEMENT FOR THE...Anthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances
EXHIBIT 10.12 SUPPLY AGREEMENTSupply Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
ANDAnthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.14 EXCLUSIVE LICENSE, SALE AND DISTRIBUTION AGREEMENT by and between ANTHRA PHARMACEUTICALS, INC.License, Sale and Distribution Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England
Lease Month Minimum Rent Due ----------- ----------------Sublease Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc
WITNESSETH:Exclusive Supply Agreement • March 11th, 1998 • Anthra Pharmaceuticals Inc
Form ofUnit and Warrant Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
FORM OF PROMOTIONAL SHARES LOCK-IN AGREEMENTAnthra Pharmaceuticals Inc • November 16th, 1998 • In vitro & in vivo diagnostic substances
JANSSEN-MEYERS ASSOCIATES, L.P. 17 State Street New York, NY 10004Anthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
WITNESSETH:Exclusive Supply Agreement • May 21st, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
2,000,000 Units, each Unit Consisting of One (1) Share of Common Stock and One (1) Redeemable Class A Common Stock Purchase Warrant ofAnthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
